Morgan Stanley Statera Biopharma, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.08 - $0.23 $4 - $13	59 Added 5900.0%	60 $0
Q3 2022 Nov 14, 2022	SELL	$0.13 - $0.28 $0 - $0	-3 Reduced 75.0%	1 $0
Q2 2022 Oct 27, 2022	SELL	$0.21 - $0.38 $1,259 - $2,278	-5,996 Reduced 99.93%	4 $0
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.38 $1,259 - $2,278	-5,996 Reduced 99.93%	4 $0
Q1 2022 Oct 27, 2022	BUY	$0.31 - $2.27 $1,858 - $13,610	5,996 Added 149900.0%	6,000 $2,000
Q1 2022 May 13, 2022	SELL	$0.31 - $2.27 $3 - $22	-10 Reduced 0.17%	6,000 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.01 - $4.08 $20 - $40	10 Added 0.17%	6,010 $14,000
Q3 2021 Nov 15, 2021	BUY	$2.29 - $6.24 $13,740 - $37,440	6,000 New	6,000 $14,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.